Eversept Partners as of June 30, 2018
Portfolio Holdings for Eversept Partners
Eversept Partners holds 68 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Quality Care Properties | 10.8 | $24M | 1.1M | 21.51 | |
R1 Rcm | 7.2 | $16M | 1.8M | 8.68 | |
Aerie Pharmaceuticals | 7.0 | $15M | 227k | 67.55 | |
Radius Health Com New | 6.3 | $14M | 469k | 29.47 | |
Zogenix Com New | 5.7 | $13M | 284k | 44.20 | |
Glaxosmithkline Sponsored Adr | 4.7 | $10M | 253k | 40.84 | |
Sanofi Sponsored Adr (SNY) | 3.9 | $8.5M | 213k | 40.01 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 3.7 | $8.1M | 30k | 271.28 | |
BioMarin Pharmaceutical (BMRN) | 3.6 | $7.9M | 84k | 94.20 | |
Teligent | 3.3 | $7.3M | 2.1M | 3.46 | |
Sage Therapeutics (SAGE) | 3.1 | $6.8M | 43k | 156.53 | |
Alnylam Pharmaceuticals (ALNY) | 2.9 | $6.3M | 64k | 98.49 | |
Ensign (ENSG) | 2.7 | $6.0M | 166k | 35.87 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $5.9M | 35k | 169.96 | |
Arena Pharmaceuticals Com New | 2.7 | $5.8M | 134k | 43.60 | |
Sarepta Therapeutics (SRPT) | 2.4 | $5.3M | 40k | 132.18 | |
Nevro (NVRO) | 1.7 | $3.8M | 47k | 79.85 | |
Abbott Laboratories (ABT) | 1.3 | $2.8M | 46k | 60.99 | |
athenahealth | 1.2 | $2.5M | 16k | 159.14 | |
Tesaro | 1.1 | $2.3M | 53k | 44.47 | |
Anaptysbio Inc Common (ANAB) | 1.1 | $2.3M | 33k | 71.04 | |
Abiomed | 1.0 | $2.3M | 5.6k | 409.05 | |
Apellis Pharmaceuticals (APLS) | 1.0 | $2.2M | 98k | 22.00 | |
ArQule | 0.9 | $2.1M | 374k | 5.53 | |
Argenx Se Sponsored Adr (ARGX) | 0.9 | $2.0M | 24k | 82.86 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 0.9 | $2.0M | 30k | 66.52 | |
Invacare Corporation | 0.8 | $1.9M | 100k | 18.60 | |
Caretrust Reit (CTRE) | 0.8 | $1.7M | 101k | 16.89 | |
Medicines Company | 0.7 | $1.4M | 39k | 36.70 | |
Cymabay Therapeutics | 0.7 | $1.4M | 107k | 13.42 | |
Amarin Corp Spons Adr New (AMRN) | 0.7 | $1.4M | 460k | 3.09 | |
Puma Biotechnology (PBYI) | 0.6 | $1.4M | 24k | 59.15 | |
Tandem Diabetes Care Com New (TNDM) | 0.6 | $1.3M | 61k | 22.02 | |
Haemonetics Corporation (HAE) | 0.6 | $1.3M | 15k | 89.68 | |
Immunomedics | 0.6 | $1.3M | 55k | 23.67 | |
Myokardia | 0.6 | $1.3M | 26k | 49.65 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $1.3M | 4.5k | 279.69 | |
eHealth (EHTH) | 0.6 | $1.2M | 57k | 22.10 | |
Anthem (ELV) | 0.5 | $1.2M | 5.0k | 238.03 | |
Akorn | 0.5 | $1.2M | 70k | 16.59 | |
Tg Therapeutics (TGTX) | 0.5 | $1.1M | 80k | 13.15 | |
Dicerna Pharmaceuticals | 0.5 | $1.0M | 85k | 12.25 | |
Centene Corporation (CNC) | 0.5 | $986k | 8.0k | 123.21 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $854k | 149k | 5.73 | |
Cellectis S A Sponsored Ads (CLLS) | 0.4 | $849k | 30k | 28.29 | |
Array BioPharma | 0.4 | $812k | 48k | 16.78 | |
Vericel (VCEL) | 0.3 | $726k | 75k | 9.70 | |
Arbutus Biopharma (ABUS) | 0.3 | $712k | 98k | 7.30 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $704k | 55k | 12.80 | |
Epizyme | 0.3 | $643k | 47k | 13.55 | |
Albireo Pharma | 0.3 | $640k | 18k | 35.50 | |
Affimed Therapeutics B V | 0.3 | $638k | 387k | 1.65 | |
Global Blood Therapeutics In | 0.3 | $624k | 14k | 45.20 | |
Foamix Pharmaceuticals SHS | 0.2 | $539k | 108k | 5.01 | |
Melinta Therapeutics | 0.2 | $488k | 77k | 6.35 | |
IntriCon Corporation | 0.2 | $484k | 12k | 40.30 | |
Model N (MODN) | 0.2 | $418k | 23k | 18.60 | |
Dynavax Technologies Corp Com New (DVAX) | 0.2 | $412k | 27k | 15.25 | |
Ophthotech | 0.2 | $407k | 149k | 2.73 | |
Peregrine Pharmaceuticals (CDMO) | 0.2 | $394k | 100k | 3.92 | |
Seaspine Holdings | 0.2 | $390k | 31k | 12.62 | |
Celyad Sa Adr | 0.2 | $382k | 13k | 29.72 | |
Deciphera Pharmaceuticals | 0.2 | $375k | 9.5k | 39.35 | |
Iradimed (IRMD) | 0.2 | $365k | 18k | 20.75 | |
Magellan Health Com New | 0.1 | $288k | 3.0k | 95.95 | |
Dermira | 0.1 | $184k | 20k | 9.20 | |
Conformis | 0.1 | $159k | 127k | 1.25 | |
Galmed Pharmaceuticals SHS | 0.1 | $119k | 10k | 11.90 |